Cytori Therapeutics has placed enrollment in its ATHENA and ATHENA I clinical trials on hold. The decision was based on a safety review of reported cerebrovascular events.
You are here
Coverage of the latest news and updates from the field of stem cells.
Regenestem, a division of Global Stem Cells Group Inc., has launched a stem cell treatment center in Cozumel, Mexico. Rafael Moguel, M.D., is the medical director.
The science world is mourning the death of a noted Japanese researcher who apparently committed suicide August 5 after being caught up in a scandal over discredited stem cell research.
Scientists say that compounds already being tested in clinical trials for other purposes might also be promising candidates for treating amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
Researchers looking to understand how to channel the ability of embryonic stem cells to develop as various cell types into the development of specific types of mature cells have found one potential way—long chains of sugars that dangle from proteins on cells’ surfaces.
Researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham), La Jolla, CA, have found that a peptide called caerulein can convert existing cells in the pancreas into the insulin-producing cells destroyed in type 1 diabetes.
Researchers at the University of Sheffield have moved one step closer to a gene therapy that could silence the faulty SOD1 gene responsible for triggering motor neurone disease (MND), also known as amyotrophic lateral sclerosis (ALS) or Lou Gehrig’s disease.
Children with severe combined immunodeficiency (SCID)—commonly known as “bubble boy syndrome”—have a high chance of survival if they receive an early stem cell transplant, a new study shows.
Scientists report the discovery of two genetic programs responsible for taking blank-slate stem cells and turning them into both red and the array of white cells that make up human blood.